Beijing Tiantan Biological Products Corporation Limited provided preliminary earnings guidance for the first quarter of 2017. For the period, the company will turn losses into gains in its business performance in the first quarter of 2017 compared with the same period of the year before, with the net profit belonging to shareholders of the listed company to be about RMB 99.58 million.